REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,137 | -53.0% | 99,129 | +3.6% | 0.00% | -60.0% |
Q2 2023 | $2,421 | -15.3% | 95,651 | +7.8% | 0.01% | -16.7% |
Q1 2023 | $2,859 | +74.4% | 88,768 | -0.1% | 0.01% | +50.0% |
Q4 2022 | $1,639 | -99.9% | 88,819 | +17.1% | 0.00% | -20.0% |
Q3 2022 | $2,047,000 | +351.9% | 75,825 | +131.1% | 0.01% | +400.0% |
Q2 2022 | $453,000 | -23.4% | 32,813 | +8.2% | 0.00% | 0.0% |
Q1 2022 | $591,000 | +46.7% | 30,313 | +22.7% | 0.00% | 0.0% |
Q4 2021 | $403,000 | -31.6% | 24,715 | +16.8% | 0.00% | 0.0% |
Q3 2021 | $589,000 | +31.5% | 21,160 | +39.8% | 0.00% | 0.0% |
Q2 2021 | $448,000 | +4.9% | 15,137 | -1.0% | 0.00% | 0.0% |
Q1 2021 | $427,000 | +14.5% | 15,285 | +16.0% | 0.00% | 0.0% |
Q4 2020 | $373,000 | +18.0% | 13,182 | +4.7% | 0.00% | 0.0% |
Q3 2020 | $316,000 | – | 12,594 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |